Approximately one‐half of individuals with cancer face personal economic burdens
associated with the disease and its treatment, a problem known as financial toxicity (FT). FT …

Significant progress has been made toward improving the care of older adults with cancer.
As described elsewhere in this Special Series, the evidence base in geriatric oncology has …

Importance Financial toxicity (FT) is the negative impact of cost of care on financial well-
being. Patients with breast cancer are at risk for incurring high out-of-pocket costs given the …

Background The overall value of hepatocellular carcinoma screening is defined by the
balance of benefits and harms. Studies have only reported physical harms with none …

Patients with cancer face an array of financial consequences as a result of their diagnosis
and treatment, collectively referred to as financial toxicity (FT). In the past 10 years, the body …

PURPOSE: Patients with hematologic malignancies are extremely vulnerable to financial
toxicity (FT) because of the high costs of treatment and health care utilization. This pilot study …

The majority of men with prostate cancer are diagnosed when they are older than 65 years;
however, clinical trial participants are disproportionately younger and more fit than the real …

The present cross-sectional prospective study (from January 2017 until December 2020)
aimed to evaluate the interrelation between nutritional parameters at the initial evaluation …

Background During the height of the coronavirus disease 2019 (COVID-19) pandemic,
elective surgeries, including oncologic surgeries, were delayed. Little prospective data …

Purpose These systematic review and meta-analysis were conducted to discuss the
financial toxicity (FT) level among breast cancer (BC) patients and the associated …